BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 9, 2009
View Archived Issues
Novel antibiotics synthesized at Cubist Pharmaceuticals
Read More
Phase II data support further development of EndoTAG/gemcitabine in pancreatic cancer
Read More
Vandetanib fails to meet primary endpoint in phase II trial in HCC patients
Read More
PK/PD data on the GLP-1 receptor agonist AVE-0010 presented at recent EASD meeting
Read More
INCB-13739 added to metformin improves HbA1c and LDL-C in type 2 diabetes patients
Read More
BI-10773 exhibits promising preclinical antidiabetic activity in rodent models
Read More
Novel 5-HT2C receptor agonist PF-3246799 shows favorable activity in animal models
Read More
Helix BioPharma presents update on development of topical interferon alpha-2b and L-DOS-47
Read More
Merz reports results from phase III study of NT-201 in post-stroke upper limb spasticity
Read More
Quest Diagnostics initiates DNA testing for Plavix response in coronary heart patients
Read More
Epigenomics launches Epi proColon blood test for early detection of colorectal cancer
Read More
Keryx initiates phase II perifosine study in CLL and SLL
Read More
Cipher begins enrollment in phase III CIP-Isotretinoin trial in severe nodular acne
Read More
Promising preclinical data support TRK-380 as a novel candidate for OAB treatment
Read More
Antisoma to amend primary endpoint of phase III trial of AS-1413 in AML
Read More
Relypsa initiates enrollment in phase IIb trial of RLY-5016 for hyperkalemia
Read More
Sanofi pasteur reports results from studies of Panenza and Humenza vaccines
Read More
IDEA reports results from two phase III studies of Diractin for osteoarthritis of the knee
Read More
Novartis gains exclusive worldwide rights to broad-spectrum PTK-0796 antibiotic from Paratek
Read More
European Commission approves Baxter's Celvapan H1N1 pandemic influenza vaccine
Read More
Cellceutix reports results of KM-133 study in human xenograft mouse model of psoriasis
Read More
Nymox reports results from phase II clinical trial of NX-1207 for BPH
Read More
FDA approves Daiichi Sankyo's sNDA for Welchol in pediatric patients with heFH
Read More
Novel antibacterial agents described by LEAD Therapeutics
Read More
Novel Jak2 inhibitors disclosed by Rigel for the treatment of cancer
Read More
Muscarinic M3 receptor antagonists claimed by AstraZeneca and Argenta Discovery
Read More